26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
Recently, we informed our readers about a new law making it more difficult to classify independent c...
Read More >
SEASON'S GREETINGS FROM PILIEROMAZZA! CLIENT ALERT: The 2020 NDAA's Impact on Government Contracto...
Read More >
The spread of COVID-19 has created a defining moment for the digital health sector, as many products...
Read More >
Over the last 18 months, a raft of publicity has propelled environmental, social and governance (ESG...
Read More >
Substantially overhauling its labor law, Mexico has enacted legislation that prohibits employer inte...
Read More >
In April 2019, Governor Jay Inslee signed SHB 1399, which amended the Washington Paid Family Medical...
Read More >